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Background: Whole-cell redox biocatalysis has been intensively explored for the production of valuable
compounds because excellent selectivity is routinely achieved. Although the cellular cofactor level, redox state and
the corresponding enzymatic activity are expected to have major effects on the performance of the biocatalysts,
our ability remains limited to predict the outcome upon variation of those factors as well as the relationship
among them.
Results: In order to investigate the effects of cofactor availability on whole-cell redox biocatalysis, we devised
recombinant Escherichia coli strains for the production of dihydroxyacetone (DHA) catalyzed by the
NAD+-dependent glycerol dehydrogenase (GldA). In this model system, a water-forming NAD+ oxidase (NOX)
and a NAD+ transporter (NTT4) were also co-expressed for cofactor regeneration and extracellular NAD+ uptake,
respectively. We found that cellular cofactor level, NAD+/NADH ratio and NOX activity were not only strain-
dependent, but also growth condition-dependent, leading to significant differences in specific DHA titer among
different whole-cell biocatalysts. The host E. coli DH5α had the highest DHA specific titer of 0.81 g/gDCW with the
highest NAD+/NADH ratio of 6.7 and NOX activity of 3900 U. The biocatalyst had a higher activity when induced
with IPTG at 37°C for 8 h compared with those at 30°C for 8 h and 18 h. When cells were transformed with the ntt4
gene, feeding NAD+ during the cell culture stage increased cellular NAD(H) level by 1.44 fold and DHA specific titer
by 1.58 fold to 2.13 g/gDCW. Supplementing NAD
+ during the biotransformation stage was also beneficial to cellular
NAD(H) level and DHA production, and the highest DHA productivity reached 0.76 g/gDCW/h. Cellular NAD(H) level,
NAD+/NADH ratio, and NOX and GldA activity dropped over time during the biotransformation process.
Conclusions: High NAD+/NADH ratio driving by NOX was very important for DHA production. Once cofactor
was efficiently cycled, high cellular NAD(H) level was also beneficial for whole-cell redox biocatalysis. Our results
indicated that NAD+ transporter could be applied to manipulate redox cofactor level for biocatalysis. Moreover, we
suggested that genetically designed redox transformation should be carefully profiled for further optimizing
whole-cell biocatalysis.
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Figure 1 Construction of recombinant E. coli strains for DHA
production. (A) Schematic representation of the engineered E. coli
for DHA production by oxidizing glycerol with NAD+ regeneration
and uptaking system; (B) Genetic arrangement of plasmids used for
DHA production. Trc P, Trc promoter; gnt105 P, gluconate transporter
promoter 105 mutation; RBS, ribosome binding site; rrnB T, rrnB
terminator; B0015, synthetic artificial terminator B0015 from IGEM.
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Cofactor-dependent redox biocatalysis has been shown
as a powerful strategy for the production of valuable
chemicals that are otherwise difficult to be synthesized
[1,2]. Whole cells are preferred for industrial application
because cofactors can be regenerated more efficiently
[1]. To drive the redox chemistry to a specified direc-
tion, it is essential to manipulate intracellular redox state
as well as cofactor levels [3]. Thus, various strategies
have been applied to control the cofactor regeneration
system or balance the enzyme activities of redox reac-
tions. For example, H2O-forming NADH oxidase (NOX)
has been applied for cofactor regeneration by engineered
whole-cell biocatalyst for chiral compound production
[4]. The intracellular cofactor concentration was also im-
portant to attain high efficiency especially in the case
that the redox enzymes had high apparent Km values to
the cofactor [5]. Previous reports showed that exogenous
supplied cofactors could improve the reaction rates un-
der whole-cell catalysis conditions, although cells were
permeated and external cofactor concentrations were
applied at concentrations of over 0.5 mM [6-9]. We
recently found that the nucleotide transporter NTT4
encoded by the ntt4 gene from the chlamydial endosym-
biont Protochlamydia amoebophila UWE25 [10] could
enable Escherichia coli cells to uptake NAD(H) from
the culture broth [11]. The NAD+ auxotrophic E. coli
YJE003 cells expressing NTT4 cultivated in the media
containing 40 μM NAD+ could realize the intracellu-
lar NAD(H) pool of 5.1 mM, which was 5.8-fold more
than that of the wild-type cells [11]. We reasoned that
such a unique NAD(H) supplementation system could be
further explored to drive cellular redox chemistry.
Glycerol has become an inexpensive and readily avai-
lable commodity as a byproduct of biodiesel industry,
which makes it attractive to convert glycerol into higher-
value products, such as 1,3-propanediol [12], glyceric
acid [13], and dihydroxyacetone (DHA) [14]. Besides the
clinical and biological applications, DHA is widely used
as building blocks in chemical industry and as an arti-
ficial suntan in cosmetic industry [15]. Gluconobacter
oxydans has been shown as an excellent DHA producer
by the oxidation of glycerol using the membrane-bound
pyrroloquinoline quinone-dependent glycerol dehydro-
genase (GDH) [16]. Native GDH contains two subunits
SldA and SldB and their membrane-associated feature
may cause problems for heterologous expression. In E.
coli, the gldA gene (ID: 6058353) encodes an endogen-
ous NAD+-dependent GDH, which catalyzes reversible
reactions for the interconversion of glycerol and DHA
[17]. However, GldA has higher affinity and specificity
(Km (DHA) = 0.3 mM vs. Km (Glycerol) = 56 mM) towards
DHA under normal physiological conditions, such that
the conversion from DHA to glycerol (kcat/Km = 5.7 ×104 M−1 s−1) by GldA is far more efficient than the
reverse reaction of glycerol to DHA (kcat/Km = 4.0 ×
102 M−1 s−1) [17]. Here, we explored the possibility
to engineer the NAD+ availability to reverse the GldA
reaction direction for DHA production. For this pur-
pose, we constructed recombinant E. coli strains that
co-expressed two genes gldA and nox, and three genes
gldA, nox and ntt4, for the production of DHA (Figure 1).
Using this system as a model, we show that cellular NAD+
availability could be manipulated by different strategies
and that the overall DHA specific titer was influenced by
enzyme activity, cellular NAD+/NADH ratio, as well as
cellular cofactor level. Our results provided useful infor-
mation for the design and evaluation of redox biocatalyst
to produce value-added chemicals.
Results
Construction of plasmids for DHA production
As no discernible DHA was observed when GldA alone
was overexpressed in E. coli whole cells (date not
shown), we introduced NOX as well as the NAD+ trans-
porter NTT4 to increase NAD+ availability. Thus, two
plasmids were constructed for DHA production from
glycerol (Figure 1). For the plasmid pTrc99A-gldA-nox,
the gldA gene from E. coli and the nox gene from
Enterococcus faecalis were cloned into the vector
pTrc99A with ribosome binding sites (RBS), under the
control of the Trc promoter and the lacI repressor
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cated downstream of nox. For the plasmid pTrc99A-
gldA-nox + ntt4, the NTT4 expression cassette in which
the ntt4 gene from P. amoebophila UWE25 was regu-
lated by the promoter gntT105 P was constructed, and
inserted into the pTrc99A-gldA-nox backbone down-
stream of the rrnBT terminator using the RF cloning
strategy [18]. Both plasmids ensured the expression of
GldA for the oxidation of glycerol to DHA and NOX for
NAD+ regeneration. In the case of pTrc99A-gldA-nox +
ntt4, NTT4 was expressed to enable NAD+ uptake.
Strain dependence of DHA production
In E. coli, intracellular cofactor concentrations varied
widely between different strains even under identical
culture conditions in previous reports (Additional file 1:
Table S1), which might affect the performance of whole-
cell biocatalysts. Such phenomena may be used as a
basis for host strain selection. A recent study showed
that the efficiencies of different E. coli strains varied
largely in the synthesis of (S)-1-(2-chlorophenyl)ethanol
[19]. In addition, our previously constructed recombi-
nant Bl21(DE3) whole-cells produced only 0.07 g/gDCW
DHA without external NAD+ supplementation [9]. Thus,
we transformed pTrc99A-gldA-nox into 6 E. coli strains
and investigated their biocatalysis profiles (Figure 2).
DHA specific titers varied greatly among different









































Figure 2 DHA production by different E. coli strains harboring the pla
30°C, and collected for biotransformation experiments in 5 mL of reaction
10 h. (A) DHA specific titer; (B) Initial enzymatic activity of GldA and NOX;
data represent the averages ± standard deviations (SDs) from three indepenhighest DHA specific titer of 0.81 g/gDCW. Recombinant
DH10B and DH1 had similar specific titer of 0.08 g/gDCW.
However, when MG1655, BW2513 or BL21(DE3) was
transformed with pTrc99A-gldA-nox, no DHA was de-
tectable. Enzyme activity assay showed that NOX activity
was well correlated with DHA titer (Figure 2B). While
DH5α had a NOX activity of 3900 U/gDCW, DH10B and
DH1 had much lower NOX activity. NOX activities for
the other three strains were below 150 U/gDCW. A high
NOX activity was beneficial for NAD+ regeneration, which
was exemplified by NAD+/NADH ratios of different
strains (Figure 2C). Indeed, DH5α, DH10B and DH1 had
a relatively higher NAD+/NADH ratios, and the ratio
reached 6.7 for DH5α. Intracellular NAD(H) levels were
shown in Figure 2D. It was apparent that DH5α and
DH10B had similar NAD(H) levels, and the other four
strains had slightly lower yet similar values. Thus, high
intracellular NAD(H) levels seemed necessary [20], but
not sufficient for high DHA productivity. Instead, high ini-
tial NAD+/NADH ratio was well correlated with DHA
titer (Figure 2A and C) and NOX activity was important
to maintain high NAD+/NADH ratio. It remains puzzling
that enzymatic activities, NAD+/NADH ratios and DHA
productivities varied in different E. coli strains regardless
of the presence of the same plasmid. However, similar
phenomenon was reported recently that tyrosine produc-
tion varied largely in 14 different E. coli strains containing











































smid pTrc99A-gldA-nox. Cells were induced by IPTG for 20 h at
buffer with 20 g/L glycerol in 50-mL test tubes at 37°C, 200 rpm for























































Figure 3 DHA production by E. coli DH5α cells harboring the
plasmid pTrc99A-gldA-nox. Cells were cultivated at 30°C or 37°C
for 8 h or 18 h after being induced by IPTG, and collected for
biotransformation experiments in 5 mL of reaction buffer with 20 g/L
glycerol at 37°C, 200 rpm for 10 h. (A) DHA specific titer; (B) Initial
enzymatic activity of GldA and NOX; (C) Initial NAD+/NADH ratio. All
data represent the averages ± SDs for three independent samples.
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To test whether expression levels of GldA and NOX
have an effect on DHA production, pTrc99A-gldA-nox
transformed E. coli DH5α cells were cultivated under
different conditions after being induced by IPTG. At
30°C, the DHA production was increased over time to
18 h. When the cell cultivated at 37°C, the DHA produc-
tion was increased when the induction time extended
from 4 h (0.62 g/g DCW) to 8 h, and dropped to below
detection after 12 h (Figure 3A). So we chose the repre-
sentative turning time point (8 h, 18 h) for enzyme activ-
ity and NAD(H) assay and investigating their correlation
with DHA production. When cells were cultivated at
30°C for 8 h or 18 h after being induced by IPTG,
intracellular NOX activities were similar. However,
GldA activity of 290 U/gDCW for the latter sample
was 2.1-fold higher than that of the former (Figure 3B). As
NAD+/NADH ratios for both samples were also similar
(Figure 3C), a higher DHA specific titer of 0.97 g/gDCW
for the latter was likely resulted from a higher GldA activ-
ity. When cells were cultivated at 37°C for 8 h, the highest
DHA specific titer of 1.78 g/gDCW was obtained to-
gether with the highest GldA activity of 440 U/gDCW.
The NAD+/NADH ratio for this sample was also slightly
higher than that of the cells cultivated at 30°C. However,
for the cells being cultivated at 37°C for 18 h, GldA
activity, NOX activity and NAD+/NADH ratio were
290 U/gDCW, 39 U/gDCW, and 3.1, respectively, which
were all substantially lower than those of other sam-
ples. As a result, DHA specific titer was only 0.01 g/gDCW.
The reason for a reduced NOX activity might be due to
the formation of protein inclusion bodies at a higher cul-
ture temperature, because NOX overexpression was toxic
to the cell [22]. These results suggested that GldA
determined the catalyst efficiency in the presence of
adequate NOX for NAD+ regeneration. Although cells
were harboring an identical plasmid, these results clearly
demonstrated that protein expression levels could be
significantly different under varied culture conditions,
leading to drastic performance differences for whole-
cell biocatalysis. Similar phenomena of culture conditions
affecting biocatalyst efficiency have been observed in a re-
cent study on L-glyceraldehyde production where glucose
dehydrogenase was used for NAD+ regeneration [7].
Promoter selection for NAD+ transporter expression
As has been demonstrated that intracellular NAD+ level
and NAD+/NADH ratio had major effects on DHA pro-
duction, we decided to further increase intracellular
NAD+ level by NAD+ feeding. We [11] and others [10]
showed that nucleotide transporter NTT4 could import
NAD+ into E. coli cells. In this study, ntt4 gene was
cloned into vectors pBCTC and pBCTD, downstream
constitutive promoters gapA P1 [23] and gntT105 P[24], to give plasmids pBCTC-ntt4 and pBCTD-ntt4, re-
spectively. Together with our previous construct pET15K-
ntt4 in which T7 promoter was used [11], three promoters
were tested. These three constructs and their correspon-
ding backbone plasmids were transformed into E. coli
DH5α cells. As shown in Table 1, when transformants
were cultivated in the presence of 0.2 mM NAD+,
pET15K-ntt4 led to 7.9% intracellular NAD+ level incre-
ment upon IPTG induction. Similarly, pBCTC-ntt4 led to





























Table 1 Intracellular NAD(H) levels of E. coli DH5α cellsa
harboring NTT4 expression and corresponding empty
plasmids
Plasmid Promoter Cellular NAD(H) level (mM)b Increment
Empty vector NTT4 expression
pET15k T7 1.72 ± 0.03 1.85 ± 0.01 7.9%
pBCTC gap P1 1.96 ± 0.00 2.13 ± 0.01 8.3%
pBCTD gntT105 P 1.86 ± 0.05 4.47 ± 0.14 141.0%
aCells were cultivated at 37°C for 12 h in LB media containing 0.2 mM NAD+,
collected by centrifugation and washed twice with PBS buffer.
bAll data represent the averages ± SDs for three independent samples.
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higher than that of pBCTD transformed cells. These
results suggested that the promoter gntT105 P was by far
the most effective one in terms of NTT4 expression for
NAD+ uptake. It should be pointed out that NTT4 is a
membrane protein such that a high NTT4 expression
seems toxic to the hosts which inhibited the cell growth
































Figure 4 DHA production by E. coli YJE005 and YJE006. Cells
were cultivated at 37°C for 8 h after being induced by IPTG, and
collected for biotransformation experiments with 20 g/L glycerol
and 0.2 mM NAD+ in 5 mL of reaction buffer in 50-mL test tubes at
37°C, 200 rpm for 10 h. (A) DHA specific titer; (B) Initial and end-point
enzymatic activity of GldA and NOX; (C) Initial and end-point cellular
NAD(H) level. All data represent the averages ± SDs for three
independent clones.Enhancing NAD+ supply for DHA production by using a
NAD+ transporter NTT4
E. coli DH5α cells were transformed with plasmids
pTrc99A-gldA-nox and pTrc99A-gldA-nox + ntt4 to
give strains YJE005 and YJE006, respectively. Both
strains were cultivated at 37°C for 8 h in the presence of
0.2 mM NAD+, and whole-cell biocatalysts were prepared.
DHA specific titer for YJE006 was 2.13 g/gDCW, which
was 1.58-fold higher than that of YJE005 (Figure 4A), sug-
gesting that NAD+ feeding during the cell culture stage
was beneficial to DHA production. Initial GldA activity
of YJE006 (250 U/gDCW) was slightly lower than that of
YJE005 (310 U/gDCW), while initial NOX activity of
YJE006 (3500 U/gDCW) was slightly higher than that of
YJE005 (3100 U/gDCW). After being used for 10 h, both
strains had significantly reduced NOX activities. While
GldA activity of YJE006 dropped to 59 U/gDCW, GldA
activity of YJE005, in sharp contrast, increased to 565
U/gDCW (Figure 4B). Initial cellular NAD(H) level and
NAD+/NADH ratio were 1.44 mM and 10.0 in YJE006,
which were 1.44-fold and 1.34-fold higher than those of
the YJE005, respectively (Figure 4C). Cellular NAD(H)
level of YJE005 dropped by only 8% to 0.92 mM, but
the NAD+/NADH ratio drastically dropped to 2.11 after
10 h. For YJE006, cellular NAD(H) level and the NAD+/
NADH ratio were dropped by 78% and 87%, respec-
tively, compared with those of the initial values. The
fact that YJE006 cells had lower initial GldA activity
but higher initial NOX activity, cellular NAD(H) level
and NAD+/NADH ratio suggested that sufficient NAD+
supply and higher cellular redox state were more im-
portant than GldA activity to drive the system for DHAproduction. However, YJE006 cells appeared to lose en-
zyme activities and cellular cofactor more rapidly than
YJE005 cells.
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In order to further investigate the NAD+ effect on the
durability of the biocatalyst, the performance of YJE006
cells for DHA production was examined under shake-
flask conditions after 2 h. When the reaction was initi-
ated with 2.0 gDCW/L cells and 2.5 g/L glycerol, DHA
concentration reached 2.08 g/L after 2 h (Figure 5A,
Line a) and the biocatalyst activity reached 96 U/gDCW.
When 5.0 g/L glycerol was used, the whole-cell cata-














a (2.5 g/L Glycerol)
b (5 g/L Glycerol)




Figure 5 DHA production by E. coli YJE006 whole cells in 20 mL
of reaction buffer in 500-mL shake-flasks at 37°C, 200 rpm.
(A) The time course of DHA formation; (B) Initial and end-point
enzymatic activity of GldA and NOX; (C) Initial and end-point cellular
NAD(H) level. The data represent the averages standard deviations
for three independent samples. All data represent the averages ± SDs
for three independent samples.biocatalyst activity of 140 U/gDCW (Figure 5A, Line
b). In both cases, DHA concentration dropped slowly
over time, suggesting that DHA may be further con-
sumed (Figure 1A). When the reaction was initiated
with 2.0 gDCW/L and 5.0 g/L glycerol in the presence
of 0.2 mM external NAD+, DHA production was
burst to 3.05 g/L within 2 h, but it was slowly in-
creasing for up to 10 h with a final titer of 3.69 g/L
(Figure 5A, Line c). However, NAD+ supplementation
failed to further improve the initial biocatalyst activity
(141 U/gDCW). Again, activities of GldA and NOX
dropped dramatically after 10 h (Figure 5B). However,
cells had higher activities of GldA and NOX as well
as NAD(H) level (b-10 h vs. c-10 h) after 10 h in the
presence of external NAD+ supplementation. These
results indicated NAD+ feeding at the biotransform-
ation stage was also slightly beneficial to DHA pro-
duction in NTT4 expressed recombinant E. coli cells.
Discussion
Cellular redox state, roughly indicated by the NAD+/
NADH ratio, is important for whole-cell redox biocataly-
sis. In E. coli, NAD+/NADH ratios ranging from 3 to 10
were previously documented [25]. It was expected that
cellular NAD+/NADH ratio as well as NAD(H) level
should have major effects on whole-cell biocatalysis.
And co-expressing the nox gene encoding a H2O-form-
ing NOX with GldA is expected to be helpful for revers-
ing GldA activity toward DHA biosynthesis by efficient
regenerating NAD+. Indeed, NOX has been widely used
to enhance NAD+-dependent biosynthesis in both
resting cells [4] and growing cells [26]. In this study,
we found NOX activity was not only strain-dependent
(Figure 2B), but also growth condition-dependent
(Figure 3B), though cells were transformed with the
same plasmid pTrc99A-gldA-nox. This may be attri-
buted to the adaption ability difference against NOX
expression among these strains because high NOX ac-
tivity retarded cell growth and affected the metabo-
lism [22]. Indeed, we also found that cell growth was
negatively correlated with NOX activity (date not
shown). Thus, while NOX expression provided driving
force to maintain a higher NAD+ level and cellular
NAD+/NADH ratio, it should be carefully tuned to
avoid toxic effects on cellular physiology. It was found
that DHA specific titer was positively correlated with
the cellular NAD+/NADH ratio but not the cellular
NAD(H) level (Figure 2). Similarly, introducing robust
cofactor regeneration system increased the whole-cell
biocatalysts efficiency [19,27]. However, enhancing the
cellular NADP(H) pool alone without efficient cofac-
tor regeneration failed to improve the redox biocata-
lyst efficiency [28]. Together, NAD+/NADH ratio driven
by a cofactor regeneration system is more important
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bioreaction.
Once cofactor was efficiently regenerated, cellular co-
factor level could also affect the biocatalyst efficiency
[20]. External cofactor supplementation has been applied
to increase intracellular NAD+ levels and NAD+/NADH
ratios [6-8]. In those cases, cells were treated with per-
meating agents and external cofactor concentrations
were high. We recently showed that NTT4 expression in
E. coli led to uptaking NAD(H) from the culture broth
[11]. Thus, ntt4 was used to improve E. coli whole-cell
biocatalytic efficiency by enhancing the cellular NAD(H)
level. Actually, ntt4 expression in YJE006 increased cel-
lular NAD(H) level by 1.44 fold, indicating that NTT4
was functional in terms of uptaking external NAD+. As
NTT4 could transport NADH efficiently [10] and in-
crease the cellular reduction state with external NADH
supplementation [11], it could also be used for increase
the cellular NADH level for reduction biocatalyst such
as asymmetric reduction of o-chloroacetophenone [8].
Although NTT4 expression strain YJE006 had a higher
DHA production, it appeared to lose enzyme activities
and cellular cofactor much more rapidly than YJE005.
One possible reason was that NTT4 expression led to
increased membrane permeability and other toxic ef-
fects. Therefore, it seemed challenging to maintain good
NAD(H) durability for NTT4 expressions cells that were
capable of uptaking external NAD+. As it requires alive
cells to mediate continuous NAD+ transportation, NTT4
may have better potential profiting for NAD+-dependent
multi-step biosynthesis in living cells such as 1-butanol
production from glucose [29]. Although the NAD+ fee-
ding strategy is cost prohibitive for bulk chemicals
production, it may be useful for the production of
high-value chemicals and pharmaceuticals. Alterna-
tively, reconstruction of efficient heterologous NAD+
biosynthesis pathway [30] may increase cellular NAD(H)
level for enhanced NAD(H)-dependent biosynthesis.
The highest specific DHA productivity reached 0.76
g/gDCW/h under shake-flask conditions for the first 2 h
(Figure 5A), which was lower compared with other
studies of more than 2 g/gDCW/h using G. oxydans as
the hosts in small scale bioreactor [31], but much
higher than that recombinant Saccharomyces cerevi-
siae of 0.03 g/gDCW/h from sugar [32]. The high
DHA productivity of G. oxydans is attributed to the
membrane-bound GDH, which can directly oxidize
glycerol to DHA without material transfer across cell
membrane [16]. However, our attempt, in reversing
an endogenous cytosolic GldA catalysis for DHA pro-
duction in recombinant E. coli by engineering NAD+
availability, provided some insights on optimizing whole-
cell redox biocatalyst for other valuable chemicals and
pharmaceuticals production.As DHA concentration dropped over time after 2 h, it
was possible that other metabolic steps consumed DHA.
In this regard, disruption of the DHA and glycerol cata-
bolic pathway related genes such as dhaK and glpK be
useful (Figure 1A). Interestingly, external NAD+ sup-
plementation during the whole-cell catalysis ensured a
higher NOX activity and continuous accumulation of
DHA for up to 10 h. These results indicated that NOX
activity was beneficial to maintain oxidative ability of the
NAD+-dependent whole-cell biocatalysis. It is worth
mentioning that the initial specific biocatalyst activity
(141 U/gDCW) was half to the initial GldA activity of 249
U/gDCW. This might be attributed to the substrate diffu-
sion, product consumption, etc.
In summary, using oxidation of glycerol to DHA by
recombinant E. coli whole-cells as a model system, we
enhanced oxidation state and cellular cofactor level for
increasing the catalytic efficiency by expressing NADH
oxidase and NAD(H) transporter, respectively. As the
overall biocatalytic performance is dependent upon the
cellular cofactor level, redox state and the corresponding
enzymatic activity, genetically designed redox transfor-
mation should be systematically profiled to identify opti-
mal whole-cell biocatalysis.
Material and methods
Bacterial strains and plasmids
Cloning and plasmid propagation were performed with
E. coli DH5α. The strains and plasmids are listed in
Table 2. E. coli was routinely cultivated with agitation at
37°C or 30°C , 200 rpm in LB broth (10 g tryptone, 5 g
yeast extract, 10 g NaCl per liter water) containing ap-
propriate antibiotics (Kanamycin sulfate, 50 μg/mL;
ampicillin, 100 μg/mL) if necessary.
Reagents
All primers used in this study (Table 3) were custom
synthesized from Invitrogen (Shanghai, China) and DNA
sequencing was performed in TaKaRa (Dalian, China).
Dpn I, PrimeSTAR HS DNA polymerase and all other
reagents for genetic manipulation were purchased from
TaKaRa (Dalian, China). DNA gel purification kit and
plasmid extraction kit were purchased from Beyotime
(Haimen, China). All chemicals were purchased from
Sigma (Shanghai, China).
DNA manipulation
The gldA (NCBI GeneID: 6058353) gene was amplified
from E. coli DH5α genomic DNA using primer pair
gldA-F0/gldA-R0 and cloned into pMD18T to give
pMD18T-gldA. The nox (NCBI GeneID: 1200486) gene
was amplified from pMD18T-nox, which was cons-
tructed by cloning the nox gene from Enterococcus fae-
calis (CGMCC 1.130) into the pMD18T. The gldA-nox
Table 2 Strains and plasmids used in this study
Strains or plasmids Genotype or characteristic Resources or references
E. coli Strains
DH5α F-, φ80d/lacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rk-, mk+), phoA,
supE44, λ-, thi-1, gyrA96, relA1
TaKaRa
DH10B F-,mcrA, Δ(mrr-hsdRMS-mcrBC), φ80lacZΔM15, ΔlacX74, recA1, endA1, araD139,
Δ (ara, leu)7697, galU, galK, λ-, rpsL, nupG/pMON14272/pMON7124
Invitrogen
DH1 F-, glnV44(AS), λ-, rfbC1, gyrA96(NalR), recA1, endA1, thi-1, hsdR17 CGSC
(No. 6040)
MG1655 F-, λ-, rph-1 CGSC
(No. 6300)
BW25113 rrnB3, ΔlacZ4787, hsdR514, Δ(araBAD)567, Δ(rhaBAD)568 rph-1 CGSC
(No. 7636)
Bl21(DE3) F–, dcm, ompT, hsdS(rB–, mB–), gal, λ(DE3) Novagen
YJE005 DH5α/pTrc99A-gldA-nox This study
YJE006 DH5α/pTrc99A-gldA-nox + ntt4 This study
Plasmids
pMD18-T lacZ, pBR322 ori, bla, cloning vector TaKaRa
pTrc99A lacI, pBR322 ori, bla, expression vector Amersham Pharmacia
pET15K-ntt4 ntt4 inserted within NdeI and BamH I sites, kan [11]
pBCTC-ntt4 ntt4 inserted within Sac I and BamH I sites, kan This study
pBCTD-ntt4 ntt4 inserted within Sac I and BamH I sites, kan This study
pTrc99A-gldA-nox gldA and nox transcription under Trc promoter This study
pTrc99A-gldA-nox + ntt4 gldA and nox transcription under Trc promoter, ntt4 under gntT105p promoter. This study








gapAP1-F1 TCGGATATCGAGGCGAGTCAGTCGCGTAATGC Promoter gapAP1 amplification
gapAP1-R1 ACCGAATTCGATCTCATATGTTCCACCAGCTATTTGTTAG
gntT105P-F1 CCGTTGATATCTGAAAGGTGTGCGCGATCTCAC PromotergntT105P amplification
gntT105P-R1 GGAATTCTATCTCCTTATTCATTTGCGCTGGGTAACGTCAATTT
ntt4-F1 TTCGAGCTCATGAGTAAAACAAACCAGG
ntt4-R1 AGAGGATCCTTAGTGATGATGATGATGATGTTTTTTTATAAAAG ntt4 amplification
gntT105P-F2 CAAACTCTTTTTGTTTATTTTTCTAAATACATGAAAGGTGTGCGCGATCTC gntT105P + ntt4 amplification
ntt4-R2 CGTTTTATTTGATGCCTGGATCCGCGTCGACTCTAGAGGATCC
T-F1 GGATCCTCTAGAGTCGACGCGGATCCAGGCATCAAATAAAACG Terminator BBa_B0015 amplification
T-R1 GTATTTAGAAAAATAAACATATAAACGCAGAAAGGCCCAC
aThe restriction sites were bolded and the ribosome binding sites (RBS) were underlined.
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dified one-step overlap extension (SOE) PCR strategy
described previously [33]. Briefly, gldA and nox were
amplified with primer pairs gldA-F1/gldA-R1 and nox-F1/
nox-R1, and purified gldA and nox fragments (molar ratio
1:1, about 200 ng each) were mixed. To the mixture were
added 3 μL of dNTP (2.5 mM each), 5 μL 5 × PrimerStar
buffer, 1.25 U PrimeSTAR HS DNA polymerase, and H2O
to a total volume of 25 μL. PCR amplification was per-
formed according to the thermocycle conditions of 95°C
for 5 min, 15 cycles of 98°C for 10 s, 68°C for 3 min, and
68°C for 10 min. Next, 2 μL of unpurified PCR products
was used as the template using the primer pair gldA-F1/
nox-R1 for normal PCR amplification in a total volume of
100 μL. The purified gldA-nox cassette was cloned into
the pTrc99A using the restriction-free (RF) cloning stra-
tegy [11] to give plasmid pTrc99A-gldA-nox.
The ntt4 (NCBI GeneID: 2780098) gene containing
the 3'-end 6 × His-tag encoding sequence was cloned
from the vector pET15k-ntt4 [11]. The constitutive
glyceraldehyde-3-phosphate dehydrogenase promoter P1
gapA P1 [23] and the internal operator of gluconate
transporter promoter 105 mutant gntT105 P [24] was
cloned from E. coli DH5α genomic DNA using primer
pairs gapAP1-F/gapAP1-R and gntT105P-F1/gntT105P-
R1, respectively. Then, EcoR V-EcoR I digested promoters
were cloned into the EcoR V-EcoR I site of pTrc99A to
substitute the Trc promoter, resulting in the constitutive
expression vectors pBCTA and pBCTB. The function of
these two vectors was checked by constitutive expression
of red fluorescent protein (date not shown). Lastly, ntt4
was cloned into the Sac I-BamH I site locating down-
stream of the constitutive promoter of pBCTA and
pBCTB after cloning with the primer pair ntt4-F1/ntt4-
R1, and the bla was replaced by the kan using a RF
cloning strategy, resulting in plasmids pBCTC-ntt4 and
pBCTD-ntt4, respectively.
The ntt4 constitutive expression cassette was also
constructed and cloned into pTrc99A-gldA-nox. The
gntT105P-ntt4 was amplified from the pBCTD-ntt4
using the primer pair gntT105P-F2/ntt4-R2 and termin-
ator B0015 cloned using the primer pair T-F1/T-R1
from the international genetically engineered machine
competition (IGEM, http://partsregistry.org/Part:BBa_
B0015). These two DNA fragments were fused with a
modified SOE PCR approach (33), and cloned into
pTrc99A-gldA-nox locating downstream of the rrnBT
terminator, resulting in plasmid pTrc99A-gldA-nox + ntt4.
Whole-cell biocatalyst preparation
Recombinant E. coli cells harboring appropriate plasmid
were cultivated in LB medium supplemented with ap-
propriate antibiotics at 37°C, 200 rpm, to the early expo-
nential phase (OD600 = 0.2–0.4). Cultures were inducedby adding IPTG to a final concentration of 0.1 mM (and
0.2 mM NAD+ if needed), and cultivated for additional
8 h or 18 h at appropriate temperature (37°C or 30°C),
200 rpm. Cells were harvested by centrifugation (2,000 g,
5 min) and washed twice with 0.1 M potassium phos-
phate buffer (pH 9.0).
DHA production
As GldA had a higher activity toward glycerol dehydro-
genation [34] and our previous study [9] showed DHA
production reached the highest at pH 9.0. The IPTG in-
duced E. coli cells were resuspended in 5 mL of 0.1 M
potassium phosphate buffer (pH 9.0) for 10 h in 5 mL of
potassium phosphate buffer containing 20 g/L glycerol
in 50-mL test tubes; or in 20 mL of the buffer containing
2–5 g/L glycerol in 500-mL shake flasks. NAD+ was
added into the reaction to a final concentration of
0.2 mM when necessary. All reactions were performed
at 37°C, 200 rpm. All the data represent the averages
standard deviations from at least three independent
samples.
DHA quantification
DHA was assayed according to a known method with
minor modifications [35]. Briefly, biotransformation mix-
tures were centrifuged at 10,000 g for 2 min. Exactly 20 μL
of supernatants were mixed with 180 μL diphenylamine
reagent containing 1% (w/v) diphenylamine and 10% (v/v)
sulfuric acid in acetic acid, and heated at 105°C for
20 min. Then, the absorbance at 620 nm were recorded
after cooling to room temperature, and DHA concentra-
tions were quantified according to a standard curve
obtained under identical conditions.
Enzyme activity assay
E. coli dry cell weight (DCW) was weight by converting
OD600 value with a coefficient of 0.275 gDCW/(L ×OD600),
which was determined by freezer drying the E. coli cells
according to our recently report [36]. As the DHA pro-
duction was performed at 0.1 M potassium phosphate
buffer (pH 9.0) due to GldA activity has higher activity as
mentioned above, all enzymatic assays were performed at
consistent pH of 9.0. About 2 × 109 E. coli cells were har-
vested, washed twice with 0.1 M potassium phosphate
buffer (pH 9.0), and stored as cell pellets at −80°C. For
enzyme assays, cell pellets were resuspended in 0.2 mL of
lysis buffer (10 mM Tris-Cl, 1.0 mM MgCl2, 1 mg/mL
lysozyme and 0.1 mg/mL DNase, pH 8.0) and incubated
at 37°C for 30 min. GldA activity was estimated by recor-
ding the absorbance increase at 340 nm and assays were
performed at 25°C, in 100 μL of 0.1 M potassium carbon-
ate buffer (pH 9.0) containing 5 mM NAD+, 100 mM gly-
cerol and 5 μL of crude cell lysates, which was with minor
modifications from a previous report [37]. NOX activity
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340 nm and assays were performed at 25°C, in 100 μL of
0.1 M potassium phosphate buffer (pH 9.0) containing
0.4 mM NADH and 1 μL (if the cell NOX activity was
more than 1000 U/gDCW) or 5 μL of (if the cell NOX
activity was less than 1000 U/gDCW) crude cell lysates.
Cofactor measurement
Cell pellets (containing about 2 × 109 cells) were washed
twice with 0.1 M potassium phosphate buffer, and
then treated at 55°C for 10 min in 150 μl of 0.2 M
NaOH (for NADH extraction) or 150 μl of 0.2 M
HCl (for NAD+ extraction). The extracts were neu-
tralized by adding 150 μl of 0.1 M HCl (for NADH
extraction) or 150 μl of 0.1 M NaOH (for NAD+ ex-
traction). The cellular debris was removed by centrifuging
at 12,000 g for 5 min. Supernatants were transferred to
new tubes and stored at −80°C until assay. NAD(H) was
quantified using a sensitive enzymatic cycling assay as
reported previously [11].
Additional file
Additional file 1: Table S1. Cellular NAD(H) level of different E. coli
strains from literatures. Figure S1. NTT4 expression under gntT105P
strongly retarded E. coli DH5α growth.
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